# Intravenous Exenatide in Patients With Acute Brain Injury

> **NCT02058940** · PHASE4 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 8 (actual)

## Conditions studied

- Brain Injuries

## Interventions

- **DRUG:** Exenatide

## Key facts

- **NCT ID:** NCT02058940
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2018-07-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02058940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02058940, "Intravenous Exenatide in Patients With Acute Brain Injury". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02058940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*